Targeted Expansion Emerging presence in stroke care events and international conferences suggests opportunities for direct outreach to neurology and emergency medicine departments, as well as collaborations with stroke centers seeking advanced coagulation diagnostics at the point of care.

Clinical Validation Recent late-breaking poster presentations at major conferences indicate ongoing clinical validation. Leverage these findings to engage hospital procurement and clinical decision teams with data-driven case studies and peer endorsements.

Strategic Partnerships Existing distributor arrangement for Ireland and new advisory board additions imply a channel-focused expansion approach. Explore additional regional distributors and clinical advisors to accelerate market access in key geographies.

Regulatory & Trust Past milestones around CE IVD marking and a focus on point-of-care coagulation diagnostics position Perosphere as a trusted partner for hospitals aiming to meet regulatory and patient-safety requirements while improving treatment decisions.

Scale & Collaboration Moderate revenue footprint with significant growth potential, indicating opportunities to upsell to larger hospital systems and forge value-based partnerships with labs and imaging/ER networks seeking faster, reliable coagulation status at the bedside.